Annual ROA
-120.33%
+80.00%+39.93%
December 1, 2023
Summary
- As of February 8, 2025, CYTO annual return on assets is -120.33%, with the most recent change of +80.00% (+39.93%) on December 1, 2023.
- During the last 3 years, CYTO annual ROA has fallen by -80.90% (-205.17%).
- CYTO annual ROA is now -293.62% below its all-time high of -30.57%, reached on December 31, 2014.
Performance
CYTO ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
N/A
June 1, 2024
Summary
- CYTO quarterly return on assets is not available.
Performance
CYTO Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
CYTO ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.9% | - |
| 3 y3 years | -205.2% | - |
| 5 y5 years | -3.4% | - |
CYTO ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.2% | +39.9% | ||
| 5 y | 5-year | -205.2% | +39.9% | ||
| alltime | all time | -293.6% | +77.4% |
Altamira Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -120.33%(-39.9%) | -41.12%(-82.5%) |
| Jun 2023 | - | -235.25%(+7.5%) |
| Dec 2022 | -200.33%(+125.1%) | -218.74%(+123.8%) |
| Jun 2022 | - | -97.75%(+45.8%) |
| Dec 2021 | -88.98%(+125.7%) | - |
| Dec 2020 | -39.43%(-45.1%) | - |
| Dec 2019 | -71.88%(-38.2%) | - |
| Jun 2019 | - | -67.05%(-39.3%) |
| Dec 2018 | -116.40%(-15.0%) | -110.47%(+10.2%) |
| Sep 2018 | - | -100.28%(+4.5%) |
| Jun 2018 | - | -95.98%(+15.9%) |
| Mar 2018 | - | -82.80%(-9.3%) |
| Dec 2017 | -136.93% | -91.31%(+18.7%) |
| Sep 2017 | - | -76.90%(+6.2%) |
| Jun 2017 | - | -72.38%(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | -77.20%(+2.7%) |
| Dec 2016 | -85.99%(+52.9%) | -75.18%(+7.5%) |
| Sep 2016 | - | -69.92%(+20.6%) |
| Jun 2016 | - | -57.99%(+4.3%) |
| Mar 2016 | - | -55.58%(+6.7%) |
| Dec 2015 | -56.25%(+84.0%) | -52.09%(+8.8%) |
| Sep 2015 | - | -47.88%(+10.4%) |
| Jun 2015 | - | -43.37%(+3.3%) |
| Mar 2015 | - | -42.00%(-7.6%) |
| Dec 2014 | -30.57%(-46.5%) | -45.47%(-21.2%) |
| Sep 2014 | - | -57.70%(-37.5%) |
| Jun 2014 | - | -92.38%(+15.9%) |
| Mar 2014 | - | -79.72%(+39.5%) |
| Dec 2013 | -57.16%(-89.2%) | -57.16% |
| Dec 2012 | -531.64% | - |
FAQ
- What is Altamira Therapeutics annual return on assets?
- What is the all time high annual ROA for Altamira Therapeutics?
- What is Altamira Therapeutics annual ROA year-on-year change?
- What is the all time high quarterly ROA for Altamira Therapeutics?
What is Altamira Therapeutics annual return on assets?
The current annual ROA of CYTO is -120.33%
What is the all time high annual ROA for Altamira Therapeutics?
Altamira Therapeutics all-time high annual return on assets is -30.57%
What is Altamira Therapeutics annual ROA year-on-year change?
Over the past year, CYTO annual return on assets has changed by +80.00% (+39.93%)
What is the all time high quarterly ROA for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly return on assets is -41.12%